Angiotensin-converting enzyme inhibitors (ACEIs) are considered primary drugs for the
secondary prevention of myocardial infarction (MI), and angiotensin receptor blockers …

Angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs)
play a role in the treatment of hypertension (HTN) and heart failure (HF). The literature …

Most guidelines for the management of patients with cardiovascular disease recommend
angiotensin-converting enzyme (ACE) inhibitors as first-choice therapy, whereas …

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are drugs
commonly used for the treatment of hypertension. However, studies on their comparative …

Context. Whether angiotensin converting‐enzyme inhibitors (ACEI) and angiotensin‐
receptor blockers (ARB) are useful in high risk patients without heart failure is unclear. We …

Background There are few reviews comparing the long-term outcomes of the use of
angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in a …

Abstract Background Angiotensin receptor blockers (ARBs) are a valuable option to reduce
cardiovascular (CV) mortality and morbidity in cardiac patients in whom ACE-inhibitors (ACE …

Patients with acute myocardial infarction (AMI) are usually treated with angiotensin-
converting enzyme inhibitors (ACEi) or angiotensin II receptor blockers (ARB). The aim of …

Objectives To compare the efficacy and safety of angiotensin-converting enzyme inhibitors
(ACEis) and angiotensin receptor blockers (ARBs) in patients without heart failure. Patients …

J Clin Hypertens (Greenwich). 2012; 14: 407–414.© 2012 Wiley Periodicals, Inc. Important
questions concerning the comparative effectiveness of angiotensin‐converting enzyme …